Pro Medicus
OrganizationHeard in 15 episodes across 3 shows since Aug 2026
An Australian medical-imaging technology company whose Visage platform supports the storage, viewing and analysis of diagnostic images.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 8 |
| Sep 2026 | 2 |
| Oct 2026 | 3 |
| Nov 2026 | 2 |
Email alert
Email me when Pro Medicus comes up on a podcast
One email a week at most, with the new episodes that mention Pro Medicus. Free, no account needed, unsubscribe in one click.
What experts have said about Pro Medicus
2 statements · 2 positive
Entering ProMedicus during volatility produced a 60% return
“Entering ProMedicus at a volatile period resulted in a 60% return.”
Open the episode · 4 Investors, $100,000: Who Won? | Portfolio ChallengeListen at 24:04
Pro Medicus’s investment thesis depends on continued operating leverage alongside 30% revenue growth.
“revenue is growing at 30 year on year but the thesis is driven by operating leverage”
Open the episode · Banks flag a housing slowdown, AI won’t pick your stocks & Ren’s portfolio reviewedListen at 29:53
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
15 episodes featuring Pro Medicus, newest first
- Nov 12, 2026
Portfolio challenge exposes the cost of chasing short-term winsEquity Mates Investing PodcastNov 12, 2026 - Nov 8, 2026
Growth investors reassess AI bets and portfolio resilienceEquity Mates Investing PodcastNov 8, 2026 - Oct 25, 2026
Data-centre backlash tests AI infrastructure’s growth storyEquity Mates Investing PodcastOct 25, 2026 - Oct 5, 2026
Australia’s policy bets collide with markets, technology and growthThe Contrarians with Adam and AdirOct 5, 2026 - Oct 4, 2026
Portfolio losses test conviction in Axon, QXO and Hub24Equity Mates Investing PodcastOct 4, 2026 - Sep 30, 2026
Rate hikes meet space bets and a portfolio overhaulEquity Mates Investing PodcastSep 30, 2026